Endovascular aortic arch repair with a pre-cannulated double-fenestrated physician-modified stent graft: a benchtop experiment.


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
27 05 2021
Historique:
received: 28 10 2020
revised: 06 12 2020
accepted: 01 01 2021
entrez: 28 5 2021
pubmed: 29 5 2021
medline: 15 10 2021
Statut: ppublish

Résumé

The critical step in total endovascular aortic arch repair is to ensure alignment of fenestrations with, and thus maintenance of flow to, supra-aortic trunks. This experimental study evaluates the feasibility and accuracy of a double-fenestrated physician-modified endovascular graft [single common large fenestration for the brachiocephalic trunk and left common carotid artery and a distal small fenestration for left subclavian artery (LSA) with a preloaded guidewire for the LSA] for total endovascular aortic arch repair. Eight fresh human cadaveric thoracic aortas were harvested. Thoracic endografts with a physician-modified double fenestration were deployed for total endovascular aortic arch repair in a bench test model. A guidewire was preloaded through the distal fenestration for the LSA. All experiments were undertaken in a hybrid room under fluoroscopic guidance with subsequent angioscopy and open evaluation for assessment. Mean aortic diameter in zone 0 was 31.3 ± 3.33 mm. Mean duration for stent graft modification was 20.1 ± 5.8 min. Mean duration of the procedure was 24 ± 8.6 min. The Medtronic Valiant Captivia stent graft was used in 6 and the Cook Alpha Zenith thoracic stent graft in 2 cases. LSA catheterization was technically successful with supra-aortic trunk patency in 100% of cases. The use of a double-fenestrated stent graft with a preloaded guidewire appears to be a useful technical addition to facilitate easy and correct alignment of stent graft fenestrations with supra-aortic trunk origins.

Identifiants

pubmed: 34047348
pii: 6287187
doi: 10.1093/icvts/ivab023
pmc: PMC8932502
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

942-949

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Références

J Endovasc Ther. 2020 Oct;27(5):785-791
pubmed: 32495679
J Endovasc Ther. 2016 Feb;23(1):160-71
pubmed: 26511895
J Endovasc Surg. 1998 Nov;5(4):310-7
pubmed: 9867319
J Thorac Cardiovasc Surg. 2014 Oct;148(4):1709-16
pubmed: 24685375
J Thorac Cardiovasc Surg. 2013 Jan;145(1):305-6
pubmed: 23040321
J Endovasc Ther. 2019 Oct;26(5):645-651
pubmed: 31240992
J Cardiovasc Surg (Torino). 2016 Oct;57(5):686-97
pubmed: 27332680
J Thorac Cardiovasc Surg. 2012 Dec;144(6):1286-300, 1300.e1-2
pubmed: 22789301
J Vasc Surg. 2013 Apr;57(4):1084-9
pubmed: 23332239
J Vasc Surg. 2020 May;71(5):1464-1471
pubmed: 32063444
J Vasc Surg. 2019 Oct;70(4):1031-1038
pubmed: 30922752
J Thorac Cardiovasc Surg. 2016 Nov;152(5):1301-1306
pubmed: 27318615
Eur J Cardiothorac Surg. 2018 May 1;53(5):1007-1012
pubmed: 29351610
J Thorac Cardiovasc Surg. 2010 May;139(5):1153-7
pubmed: 19660344

Auteurs

Youcef Lounes (Y)

Department of Vascular and Thoracic Surgery, Arnaud de Villeneuve Hospital, Montpellier, France.
Arnaud de Villeneuve Hospital, INSERM U1046, UM1, CHRU of Montpellier, Montpellier, France.

Lucien Chassin-Trubert (L)

Department of Vascular and Thoracic Surgery, Arnaud de Villeneuve Hospital, Montpellier, France.
Arnaud de Villeneuve Hospital, INSERM U1046, UM1, CHRU of Montpellier, Montpellier, France.

Thomas Gandet (T)

Department of Cardio-Vascular Surgery, Arnaud de Villeneuve Hospital, Montpellier, France.

Baris Ata Ozdemir (BA)

Department of Vascular and Thoracic Surgery, Arnaud de Villeneuve Hospital, Montpellier, France.
Arnaud de Villeneuve Hospital, INSERM U1046, UM1, CHRU of Montpellier, Montpellier, France.
Arnaud de Villeneuve Hospital, University of Bristol, Bristol, UK.

Antoine Peyron (A)

Legal Department, Lapeyronie Hospital, Montpellier, France.

Mariama Akodad (M)

Cardiology Department, Montpellier University Hospital, Montpellier, France.

Pierre Alric (P)

Department of Vascular and Thoracic Surgery, Arnaud de Villeneuve Hospital, Montpellier, France.
Arnaud de Villeneuve Hospital, INSERM U1046, UM1, CHRU of Montpellier, Montpellier, France.

Ludovic Canaud (L)

Department of Vascular and Thoracic Surgery, Arnaud de Villeneuve Hospital, Montpellier, France.
Arnaud de Villeneuve Hospital, INSERM U1046, UM1, CHRU of Montpellier, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH